ECM
INSM icon

ExodusPoint Capital Management’s Insmed INSM Stock Holding History

ExodusPoint Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$1.67M – 1826
2024
Q2 		$1.67M Hold
25,000
– – 0.01% 843
2024
Q1 		$680K Buy
+25,000
New +$700K 0.01% 1065

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ExodusPoint Capital Management's INSM Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Insmed (INSM) stake by 85% in Q1 2026, buying an estimated $10.5M and bringing the position to 148,133 shares worth $24.2M. The position accounts for 0.19% of the portfolio, ranked #74.

ExodusPoint Capital Management first reported a position in INSM in Q3 2019 and has held it in 16 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • ExodusPoint Capital Management held 148,133 shares of Insmed worth $24.2M as of Q1 2026.
  • ExodusPoint Capital Management bought 68,046 Insmed shares in Q1 2026, an estimated $10.5M.
  • Insmed made up 0.19% of ExodusPoint Capital Management's portfolio in Q1 2026, its #74 holding.
  • ExodusPoint Capital Management first reported a position in Insmed in Q3 2019 and has held it in 16 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.